Filter
159
Filtered Results: 159
Text search:
genotypic
testing
Featured
Recommendations
25
New Publications
48
Language
Document type
No document type
93
Guidelines
32
Studies & Reports
23
Manuals
6
Strategic & Response Plan
4
Fact sheets
1
Countries / Regions
India
8
Western and Central Europe
6
Ethiopia
5
Africa
4
Eastern Europe
4
Myanmar / Burma
3
Zambia
2
Kenya
2
Malawi
2
Mozambique
2
Latin America and the Carribbean
2
Asia
2
Russia
2
Estonia
2
Sierra Leone
1
Nigeria
1
Senegal
1
USA
1
Uganda
1
Philippines
1
Tanzania
1
Thailand
1
South Africa
1
Bangladesh
1
Benin
1
North Macedonia
1
Colombia
1
Botswana
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Georgia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
40
Clinical Guidelines
30
Pharmacy & Technologies
10
Public Health
8
Capacity Building
1
Women & Child Health
1
Key Resources
1
Toolboxes
TB
51
HIV
28
AMR
15
Rapid Response
5
COVID-19
5
NTDs
5
Mental Health
3
Pharmacy
3
Polio
2
Refugee
2
Ebola
1
Natural Hazards
1
Caregiver
1
NCDs
1
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide i...
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of te...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan ...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
A survey of prevention, testing and treatment policies and practices
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
3rd Edition – July 2017
www.msfaccess.org
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
